Muscle-Sparing Effect Of Human Chorionic Gonadotropin (hCG) During a Very Low Calorie Diet (VLCD)

• Status: Completed
• Trial end date: 2012-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

Subjects are female patients, randomized to HCG group or placebo group, during a prospective trial, in order to determine the significance, if any, of HCG on maintaining muscle mass during a very low calorie diet in order to demonstrate the potential significance of HCG administration on preserving lean body mass while losing weight.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Dr. Emma's Corporation
• Treatments: Chorionic Gonadotropin

Criteria

Inclusion Criteria:

• Body Mass Index (BMI) greater than 30,

• Female,

• good health

Exclusion Criteria:

• complex medical history,

• thyroid disease,

• BMI less than 30,

• psychological instability or history of eating disorder